Zobrazeno 1 - 7
of 7
pro vyhledávání: '"David Benzaquen"'
Autor:
Matthieu Vermeille, Kira-Lee Koster, David Benzaquen, Ambroise Champion, Daniel Taussky, Kevin Kaulanjan, Martin Früh
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9886-9894 (2023)
Background: Despite recent awareness of institutional racism, there are still important racial disparities in prostate cancer medical research. We investigated the historical development of research on racial disparities and bias. Methods: PubMed was
Externí odkaz:
https://doaj.org/article/86620ec0d5db411a8dbc9e3a969d6927
Autor:
Ambroise Champion, Daniel Rudolf Zwhalen, Christoph Oehler, Daniel Taussky, Stephanie G. C. Kroeze, Irene A. Burger, David Benzaquen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
There are few randomized trials to evaluate the use of PSMA-PET in the planning of post-prostatectomy radiotherapy. There are two unresolved questions 1) should we increase the dose to lesions visible on PSMA-PET 2) can we reduce dose in the case of
Externí odkaz:
https://doaj.org/article/bb2c45dce2ee4248811083c09dd966be
Publikováno v:
Médecine et Maladies Infectieuses Formation. 2:98-100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1c26cb395cf3f92b82cdb097a4b3f6d
https://doi.org/10.1016/j.mmifmc.2023.01.006
https://doi.org/10.1016/j.mmifmc.2023.01.006
Prostate-specific antigen density is predictive of outcome in suboptimal prostate seed brachytherapy
Publikováno v:
Brachytherapy. 16(2)
Purpose In prostate seed brachytherapy, a D90 of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b3e20f5cd935ccedf9e9506bb6e90fc
https://pubmed.ncbi.nlm.nih.gov/28366277
https://pubmed.ncbi.nlm.nih.gov/28366277
Autor:
Christian Recher, Guy Laurent, Véronique Mansat-De Mas, Gaëtan Chicanne, Françoise Huguet, Bernard Payrastre, Cécile Demur, Cedric Dos Santos, Odile Beyne-Rauzy, David Benzaquen
Publikováno v:
Blood. 105(6)
The mammalian target of rapamycin (mTOR) is a key regulator of growth and survival in many cell types. Its constitutive activation has been involved in the pathogenesis of various cancers. In this study, we show that mTOR inhibition by rapamycin stro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ad318e66451e767f92123914c9a1ef2
https://pubmed.ncbi.nlm.nih.gov/15550488
https://pubmed.ncbi.nlm.nih.gov/15550488
Publikováno v:
Revue de Chirurgie Orthopédique et Réparatrice de l'Appareil Moteur. 90:78-79
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16fb46805578b1289270bd7994945323
https://doi.org/10.1016/s0035-1040(04)70566-8
https://doi.org/10.1016/s0035-1040(04)70566-8
Publikováno v:
Revue de Chirurgie Orthopédique et Réparatrice de l'Appareil Moteur. 90:124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::301826e6d72b518077c6a052aeeb1d51
https://doi.org/10.1016/s0035-1040(04)70656-x
https://doi.org/10.1016/s0035-1040(04)70656-x